Hefei Lifeon Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 7.57%

Hefei Lifeon Pharmaceutical Co Ltd (003020) has an Asset Resilience Ratio of 7.57% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥200.53 Million

≈ $29.34 Million USD Cash + Short-term Investments

Total Assets

CN¥2.65 Billion

≈ $387.83 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how Hefei Lifeon Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check Hefei Lifeon Pharmaceutical Co Ltd (003020) strategic asset index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Hefei Lifeon Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Hefei Lifeon Pharmaceutical Co Ltd (003020) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥200.53 Million	7.57%
Total Liquid Assets	CN¥200.53 Million	7.57%

Asset Resilience Insights

Limited Liquidity: Hefei Lifeon Pharmaceutical Co Ltd maintains only 7.57% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Hefei Lifeon Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Hefei Lifeon Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Hefei Lifeon Pharmaceutical Co Ltd (2021–2025)

The table below shows the annual Asset Resilience Ratio data for Hefei Lifeon Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.56%	CN¥40.27 Million ≈ $5.89 Million	CN¥2.59 Billion ≈ $378.39 Million	-0.69pp
2024-12-31	2.24%	CN¥58.00 Million ≈ $8.49 Million	CN¥2.59 Billion ≈ $378.41 Million	-0.23pp
2023-12-31	2.48%	CN¥61.52 Million ≈ $9.00 Million	CN¥2.48 Billion ≈ $363.44 Million	+2.47pp
2022-12-31	0.01%	CN¥115.39K ≈ $16.88K	CN¥2.12 Billion ≈ $310.48 Million	0.00pp
2021-12-31	0.01%	CN¥132.55K ≈ $19.40K	CN¥1.67 Billion ≈ $245.02 Million	--

pp = percentage points

About Hefei Lifeon Pharmaceutical Co Ltd

SHE:003020 China Biotechnology

Market Cap

$565.39 Million

CN¥3.86 Billion CNY

Market Cap Rank

#11460 Global

#3192 in China

Share Price

CN¥16.93

Change (1 day)

+0.36%

52-Week Range

CN¥14.66 - CN¥38.76

All Time High

CN¥38.76